Literature DB >> 34625664

Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients.

Elisabetta Xue1, Francesca Lorentino1,2, Maria Teresa Lupo Stanghellini1, Raffaella Greco3, Daniela Clerici1, Francesca Farina1, Chiara Oltolini4, Fabio Giglio1, Edoardo Campodonico1,5, Rosamaria Nitti1,5, Massimo Bernardi1, Consuelo Corti1, Jacopo Peccatori6, Fabio Ciceri1,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34625664     DOI: 10.1038/s41409-021-01486-5

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  1 in total

1.  Letermovir Prophylaxis for Cytomegalovirus.

Authors:  Francisco M Marty; Johan Maertens; Cyrus Badshah
Journal:  N Engl J Med       Date:  2018-03-08       Impact factor: 91.245

  1 in total
  1 in total

1.  Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia.

Authors:  Lorenzo Lazzari; Aitana Balaguer-Roselló; Jacopo Peccatori; Jaime Sanz; Juan Montoro; Raffaella Greco; Rafael Hernani; Maria Teresa Lupo-Stanghellini; Marta Villalba; Fabio Giglio; Ana Facal; Francesca Lorentino; Manuel Guerreiro; Alessandro Bruno; Ariadna Pérez; Elisabetta Xue; Daniela Clerici; Simona Piemontese; José Luis Piñana; Miguel Ángel Sanz; Carlos Solano; Javier de la Rubia; Fabio Ciceri
Journal:  Bone Marrow Transplant       Date:  2022-06-09       Impact factor: 5.174

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.